NO985294L - Kontrastmidler - Google Patents

Kontrastmidler

Info

Publication number
NO985294L
NO985294L NO985294A NO985294A NO985294L NO 985294 L NO985294 L NO 985294L NO 985294 A NO985294 A NO 985294A NO 985294 A NO985294 A NO 985294A NO 985294 L NO985294 L NO 985294L
Authority
NO
Norway
Prior art keywords
group
integer
alkyl
contrast media
aryl
Prior art date
Application number
NO985294A
Other languages
English (en)
Norwegian (no)
Other versions
NO985294D0 (no
Inventor
Jeffrey Long
Richard Holm
William Sanderson
Shi-Bao Yu
Zhiping Zheng
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of NO985294D0 publication Critical patent/NO985294D0/no
Publication of NO985294L publication Critical patent/NO985294L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C07F15/008—Rhodium compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO985294A 1996-05-14 1998-11-13 Kontrastmidler NO985294L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64900096A 1996-05-14 1996-05-14
US08/704,009 US5804161A (en) 1996-05-14 1996-08-26 Contrast agents
PCT/GB1997/001314 WO1997043293A1 (en) 1996-05-14 1997-05-14 Contrast agents

Publications (2)

Publication Number Publication Date
NO985294D0 NO985294D0 (no) 1998-11-13
NO985294L true NO985294L (no) 1999-01-13

Family

ID=27095513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985294A NO985294L (no) 1996-05-14 1998-11-13 Kontrastmidler

Country Status (9)

Country Link
US (1) US5804161A (de)
EP (1) EP0901496A1 (de)
JP (1) JP2000510838A (de)
KR (1) KR20000011027A (de)
CN (1) CN1227562A (de)
AU (1) AU2784397A (de)
CA (1) CA2253307A1 (de)
NO (1) NO985294L (de)
WO (1) WO1997043293A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) * 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
EP1140864A2 (de) * 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend
CA2349501A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
WO2001087354A2 (en) * 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
CN1386118A (zh) * 2000-06-01 2002-12-18 布里斯托尔-迈尔斯斯奎布药品公司 作为Aβ蛋白产生抑制剂的被环状琥珀酸酯取代的内酰胺类化合物
HUP0400758A3 (en) 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
MXPA04001113A (es) * 2001-08-08 2004-07-08 Bristol Myers Squibb Pharma Co Formacion de imagenes simultaneas de perfusion cardiaca y agente formador de imagenes dirigido al receptor de vitronectina.
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050106101A1 (en) * 2003-10-31 2005-05-19 Ajay Purohit Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
US7485283B2 (en) 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US20060083681A1 (en) * 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
US7858380B2 (en) * 2005-01-28 2010-12-28 Board Of Trustees Of Michigan State University Sol-gel encapsulated hexanuclear clusters for oxygen sensing by optical techniques
KR20080022588A (ko) * 2005-06-30 2008-03-11 브리스톨-마이어스 스퀴브 파마 컴퍼니 영상화제로서의 히드라지드 컨쥬게이트
US7824659B2 (en) 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
KR100820963B1 (ko) 2006-10-16 2008-04-11 엘지전자 주식회사 플라즈마 디스플레이 패널
KR20090095626A (ko) 2006-12-04 2009-09-09 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신과 ＣｐＧ 리치 ＤＮＡ를 이용한 조성물 및 암 치료 방법
AU2008212788A1 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
WO2009110984A2 (en) * 2008-02-29 2009-09-11 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
ES2770364T3 (es) 2009-04-15 2020-07-01 Lantheus Medical Imaging Inc Estabilización de composiciones radiofarmacéuticas utilizando ácido ascórbico
WO2011035140A1 (en) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of contrast moieties to the lungs
RU2631500C2 (ru) 2010-02-08 2017-09-25 Лантеус Медикал Имаджинг, Инк. Способы и устройство для синтезирования радиофармацевтических препаратов и их промежуточных продуктов
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
RU2624776C2 (ru) * 2015-10-28 2017-07-10 Федеральное государственное бюджетное учреждение науки Институт неорганической химии им. А.В. Николаева Сибирского отделения Российской академии наук Способ получения трис(2-карбоксиэтил)фосфиновых октаэдрических халькогенидных кластерных комплексов рения (варианты)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions

Also Published As

Publication number Publication date
CN1227562A (zh) 1999-09-01
JP2000510838A (ja) 2000-08-22
WO1997043293A1 (en) 1997-11-20
CA2253307A1 (en) 1997-11-20
AU2784397A (en) 1997-12-05
KR20000011027A (ko) 2000-02-25
EP0901496A1 (de) 1999-03-17
US5804161A (en) 1998-09-08
NO985294D0 (no) 1998-11-13

Similar Documents

Publication Publication Date Title
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
ES8401468A1 (es) Un procedimiento para preparar derivados de nicotinamida.
ES8100281A1 (es) Un procedimiento para la preparacion de un compuesto de guanidinotiazol
EP0392376A3 (de) N-Acylderivate der Antitumor-Antibiotika vom Typ LL-E33288
UA37230C2 (uk) Полі-1-н-алкенаміни та склади палива або мастильного засобу, що їх містять
GB2346878A (en) Preparation of 3-substituted adenines
IL115420A0 (en) Aminoheterocyclic derivatives
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
HUT72192A (en) Compounds useful as sweeting agents, sweeting composition containing them and process for their preparation
GB9017024D0 (en) New linker for bioactive agents
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
ES445790A1 (es) Procedimiento para preparar derivados de 3-formilrifamicina sv.
WO1996020185A3 (en) Tetrahydrofurans and tetrahydropyrans
ES8607980A1 (es) Procedimiento para la obtencion de muramilpeptidos
TW324029B (en) De-oiling cleaner composition
ES8503354A1 (es) Un procedimiento de preparacion de nuevos derivados de carbapenem.
CA2054895A1 (en) 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation
HK74687A (en) Azino methyl-rifamycins
YU25699A (sh) Novi derivati eritromicina, postupak za njihovu izradu i njihova primena
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
PL341837A1 (en) Novel tricyclic compounds, method of obtaining them and pharmacological compositions containing such compounds
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
IE812876L (en) Ethers of substituted hydroxymethylpyrazines
ES2165917T3 (es) Nuevos compuestos 2,6-di-tert-butilfenoles sustituidos en posicion 4, composiciones farmaceuticas que los contienen y su procedimiento de preparacion.
ES444091A1 (es) Un metodo de preparar nuevos derivados de 10-piperazinodi- benzo (b, f) itepina polisustituidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application